N-[(1S,3R,9S,12R,15S)-3,12-DIMETHYL-4,10,13-TRIOXO-2-THIA-5,11,14-TRIAZATRICYCLO-[12.2.1.0(5,9)]-HEPTADECAN-15-YLCARBONYL]-N,N'-(DIMETHYL)-ETHYLEN
Compound with spectra: 1 NMR
![N-[(1S,3R,9S,12R,15S)-3,12-DIMETHYL-4,10,13-TRIOXO-2-THIA-5,11,14-TRIAZATRICYCLO-[12.2.1.0(5,9)]-HEPTADECAN-15-YLCARBONYL]-N,N'-(DIMETHYL)-ETHYLEN](/api/compound/M4WtyNdZTV.png?ph=true&h=300&w=458 "N-[(1S,3R,9S,12R,15S)-3,12-DIMETHYL-4,10,13-TRIOXO-2-THIA-5,11,14-TRIAZATRICYCLO-[12.2.1.0(5,9)]-HEPTADECAN-15-YLCARBONYL]-N,N'-(DIMETHYL)-ETHYLEN")
| SpectraBase Compound ID | M4WtyNdZTV |
|---|---|
| InChI | InChI=1S/C20H33N5O4S/c1-12-19(28)25-11-14(10-16(25)17(26)21-7-9-23(3)4)30-13(2)20(29)24-8-5-6-15(24)18(27)22-12/h12-16H,5-11H2,1-4H3,(H,21,26)(H,22,27)/t12-,13+,14?,15-,16?/m0/s1 |
| InChIKey | ZMMLJYXRLKFAJU-LXINESAQSA-N |
| Mol Weight | 439.6 g/mol |
| Molecular Formula | C20H33N5O4S |
| Exact Mass | 439.225326 g/mol |
| Enantiomer InChIKey | ZMMLJYXRLKFAJU-WJTFHPDPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,3R,9S,12R,15S)-3,12-DIMETHYL-4,10,13-TRIOXO-2-THIA-5,11,14-TRIAZATRICYCLO-[12.2.1.0(5,9)]-HEPTADECANE-15-CARBOXYLIC-ACID
N-ALLYLOXYCARBONYL-(S-PALMITOYL)-L-CYSTEYL-L-METHIONYL-GLYCYL-L-LEUCYL-L-PROLYL-(S-FARNESYL)-L-CYSTEINE-METHYLESTER;ALOCCYS(PAL)-METGLYLEUPROCYS-(F
N^2-{N-{1-{N-{N-{N-[N-(1-L-ARGINYL-L-PROLYL)-L-ALANYL]GLYCYL}-3-PHENYL-L-ALANYL}-L-SERYL}-L-PROLYL}-3-PHENYL-L-ALANYL}ARGININE, DIACETATE (SALT), HYDRATED
CYCLOMONTANIN-D;CYCLO-(-ASPARAGINYL-PROLYL-GLYCYL-LEUCYL-PROLYL-TYROSINYL-ALANYL-)
DELAVAYIN-C;CYClO-(-GLY-TYR-TYR-TYR-PRO-VAL-PRO-)
N-(6-MALEIMIDOCAPROYL)-GLYCYL-S-TERT.-BUTYLTHIO-L-CYSTEYL-L-METHIONYLGLYCYL-L-LEUCYL-L-PROLYL-S-FARNESYL-L-CYSTEINE-METHYLESTER
3-[2-[2-[2-[[2-[[1-[2-[[2-[[2-[[2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenyl-propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-butanoyl]oxyethoxy]ethoxy]p
N-(6-MALEIMIDOCAPROYL)-GLYCYL-S-PALMITOYL-L-CYSTEYL-L-METHIONYLGLYCYL-L-LEUCYL-L-PROLYL-S-HEXADECYL-L-CYSTEINE-METHYLESTER
N-TERT.-BUTYLOXYCARBONYLGLYCYL-S-PALMITOYL-L-CYSTEYL-L-METHIONYLGLYCYL-L-LEUCYL-L-PROLYL-S-HEXADECYL-L-CYSTEINE-METHYLESTER
N-(6-MALEIMIDOCAPROYL)-GLYCYL-S-TERT.-BUTYLTHIO-L-CYSTEYL-L-METHIONYLGLYCYL-L-LEUCYL-L-PROLYL-S-HEXADECYL-L-CYSTEINE-METHYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| Design, construction and properties of peptide N-terminal cap templates devised to initiate α-helices. Part 3.† Caps derived from N-[(2S )-2-chloropropionyl]-(2S )-Pro-(2R)-Ala-(2S,4S )-4-thioPro-OMe | Journal of the Chemical Society, Perkin Transactions 1 | 1998 |